JNJ

J & J’s Covid-19 Vaccine: How Effective Is It and When Will It Be Available?

Vaccine expectations are boosted by data from Novavax and J&J, but fears about new variants remain

General Electric, 3M, Etsy: What to look for when the stock market opens today

It was a gloomy morning in the Covid-19 battle. The market is looking at Johnson & Johnson for hope.

J&J could share the results of the phase 3 vaccine study this week

The “latest hurricane” of technology? If hedge funds are any indication, it could be a big week for Apple, Amazon and other prominent megacaps

Johnson & Johnson aims for 100 million doses of vaccine by spring. The stock market is based on it.

J&J Hits Vaccine Production Snags, New York Times Report

Covid-19 vaccines expected to work on South African coronavirus strain

Three more coronavirus vaccines expected by early 2021